Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis

Purpose: To elucidate the efficacy and safety profile of interferon α-2b in vernal keratoconjunctivitis (VKC). Methods: In this prospective interventional study, VKC patients fulfilling the inclusion and exclusion criteria were included and their signs and symptoms were scored based on the Clinical...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Indian Journal of Ophthalmology
المؤلفون الرئيسيون: Saurabh Ramdas Haral, Taskin Khan, Vishnu S Gupta, Madhura Sanjay Ukalkar
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Wolters Kluwer Medknow Publications 2024-03-01
الموضوعات:
interferon alpha 2b
vernal keratoconjunctivitis
topical treatment
symptom score
الوصول للمادة أونلاين:https://journals.lww.com/10.4103/IJO.IJO_1393_23

الانترنت

https://journals.lww.com/10.4103/IJO.IJO_1393_23

مواد مشابهة